© 2026 Buobe

The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug | Buobe

The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug

Published by

alumni.weill.cornell.edu

on •1 min read

Jacob Wilson knew something had tangibly changed just six months into a clinical trial evaluating an innovative therapy that targets mitochondria, the energy producing structures inside cells.